CONDUIT PHARMACEUTICALS INC. Annual Share-based Payment Arrangement, Expense in USD for 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Conduit Pharmaceuticals Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate for 2023.
  • Conduit Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $10K.
Share-based Payment Arrangement, Expense, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $400K Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.